Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ammonia oxidation pathway is a central component of the global nitrogen cycle, responsible for the aerobic conversion of ammonia (NH₃) to nitrite (NO₂⁻) and then to nitrate (NO₃⁻) via nitrifying microorganisms. The initial oxidation of ammonia to hydroxylamine is catalyzed by ammonia monooxygenase (AMO), a copper-containing membrane-bound enzyme found in ammonia-oxidizing bacteria (AOB) and archaea (AOA). Hydroxylamine is subsequently oxidized to nitrite by hydroxylamine oxidoreductase (HAO). Some bacteria (comammox, e.g., certain Nitrospira) are capable of complete ammonia oxidation to nitrate within a single organism. These reactions are essential for nitrogen turnover in soils, aquatic systems, and engineered environments such as wastewater treatment plants. The pathway itself is not a drug target, but the key enzymes (such as AMO) may be targeted to inhibit nitrification in agricultural and environmental contexts.
Enzyme inhibition (e.g., covalent or competitive inhibition of AMO prevents the oxidation of ammonia, thereby inhibiting nitrification)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ammonia oxidation pathway.